2021
DOI: 10.3389/fimmu.2021.798003
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression

Abstract: Human endogenous retrovirus W family envelope proteins (pHERV-W ENV/syncytin-1) have been repeatedly associated with multiple sclerosis (MS). Here, we have focused on the study of pHERV-W ENV/syncytin-1 expression levels in MS patients (relapsing and progressive forms) and in healthy donors (HD) and on exploring their possible relationship with Epstein-Barr virus (EBV) and human herpesvirus-6A/B (HHV-6A/B). We included blood samples from 101 MS patients and 37 HD to analyze antiviral antibody titers by ELISA a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 50 publications
1
6
0
Order By: Relevance
“…Our study reaffirms the connection between pHERV-W protein and disease severity, highlighting that even slight variations in amino acidic sequences between peptides can influence the immunological response. Consistent with our result, previous studies have reported higher gene expression levels of pHERV-W protein compared to syncytin-1 in patients with primary progressive and RRMS [26]. Moreover, elevated levels of extracellular RNA viral loads and HERV-Fc1 gag gene expression were detected in AMS patients compared to SMS and HCs [27].…”
Section: Discussionsupporting
confidence: 92%
“…Our study reaffirms the connection between pHERV-W protein and disease severity, highlighting that even slight variations in amino acidic sequences between peptides can influence the immunological response. Consistent with our result, previous studies have reported higher gene expression levels of pHERV-W protein compared to syncytin-1 in patients with primary progressive and RRMS [26]. Moreover, elevated levels of extracellular RNA viral loads and HERV-Fc1 gag gene expression were detected in AMS patients compared to SMS and HCs [27].…”
Section: Discussionsupporting
confidence: 92%
“…By carrying stretches of telomeric repeats at their linear genome, the variants HHV-6A and HHV-6B are able to integrate into human chromosomes and become latent [ 160 ]. This virus has been found in several human diseases, including autoimmunity [ 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 ], ME/CFS [ 190 , 191 , 192 , 193 ], mitochondrial dysfunction [ 193 , 194 ], and in patients with moderate to critical COVID-19 [ 42 , 43 , 44 , 195 , 196 ]. Among the autoimmune diseases associated with HHV-6, the most frequently cited is multiple sclerosis (MS) [ 170 , 171 , 172 , 173 , 174 , 175 , 176 , …”
Section: Multiple Tissue Damage and Autoimmunitymentioning
confidence: 99%
“…This has been demonstrated by the direct detection of the HHV-6 genome and antigens in the blood and brain of patients with MS [ 176 , 177 , 178 , 181 , 182 , 183 ]. Furthermore, not only were higher levels of anti-HHV-6 A/B antibodies detected in the blood of MS patients, their titers also correlated with the severity of the disease [ 170 ] and in predicting risk of relapse [ 184 , 185 , 186 ]. Researchers further concluded that in addition to its potential etiologic role in MS, infection with HHV-6 or immune reaction against it may also have an effect on MS relapse and its progression [ 184 ].…”
Section: Multiple Tissue Damage and Autoimmunitymentioning
confidence: 99%
See 1 more Smart Citation
“…cDNA was synthesized from RNA using the Transcriptor First Strand cDNA Synthesis kit (Roche Diagnostics, S.L., Barcelona, Spain), where negative controls (without retrotranscriptase) were included. For pHERV-W ENV and syncytin-1 gene expression quantification, we followed our previously published protocol [ 17 ].…”
Section: Methodsmentioning
confidence: 99%